Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

PNAS 97 (3): 1032-1037

Copyright © 2000 by the National Academy of Sciences.


BIOLOGICAL SCIENCES / BIOCHEMISTRY

Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome

Carol A. Lange*, Tianjie Shen, and Kathryn B. Horwitz{dagger}

Department of Medicine, The Molecular Biology Program, and The Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, CO 80262

Received for publication September 1, 1999.

Abstract: Ligand-dependent down-regulation that leads to rapid and extensive loss of protein is characteristic of several nuclear steroid receptors, including human progesterone receptors (PRs). In breast cancer cells, >95% of PRs are degraded 6 h after the start of progestin treatment. The mechanism for down-regulation is unknown. We examined the role of PR phosphorylation by mitogen-activated protein kinases (MAPKs) in this process. Lactacystin and calpain inhibitor I, specific inhibitors of the 26S proteasome, blocked progestin-induced down-regulation, and ubiquitinated conjugates of PR accumulated in cells. Ligand-dependent PR degradation was also blocked by specific inhibition of p42 and p44 MAPKs. To define the targets of phosphorylation by this kinase, two serine/proline MAPK consensus sites on PR were mutated. We demonstrate that mutation of PR serine-294 to alanine (S294A) specifically and completely prevents ligand-dependent receptor down-regulation. We also find that rapid, ligand-independent degradation of immature PR intermediates occurs by a proteasome-mediated pathway. These results demonstrate that PR destruction, by either of two alternate routes, is mediated by the 26S proteasome. Specifically, down-regulation of mature PRs occurs by a mechanism in which ligand binding activates PR phosphorylation by MAPKs at a unique serine residue, which then targets the receptors for degradation.


* Present address: University of Minnesota Cancer Center and Department of Medicine, University of Minnesota, Minneapolis, MN 55455.

{dagger} To whom reprint requests should be addressed. E-mail: kate.horwitz{at}UCHSC.edu.

Edited by Ronald M. Evans, The Salk Institute for Biological Studies, San Diego, CA, and approved November 30, 1999

This paper was submitted directly (Track II) to the PNAS office.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Acetylation at Lysine 183 of Progesterone Receptor by p300 Accelerates DNA Binding Kinetics and Transactivation of Direct Target Genes.
H. H. Chung, S. K. Sze, A. S. L. Tay, and V. C.- L. Lin (2014)
J. Biol. Chem. 289, 2180-2194
   Abstract »    Full Text »    PDF »
Smoking Out Reproductive Hormone Actions in Lung Cancer.
J. M. Siegfried (2014)
Mol. Cancer Res. 12, 24-31
   Abstract »    Full Text »    PDF »
A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.
C. R. Hagan, T. P. Knutson, and C. A. Lange (2013)
Nucleic Acids Res. 41, 8926-8942
   Abstract »    Full Text »    PDF »
Progesterone Receptor A Stability Is Mediated by Glycogen Synthase Kinase-3{beta} in the Brca1-deficient Mammary Gland.
S. Wang, Y. Li, P.-H. Hsu, S.-Y. Lee, Y. Kim, and E. Y.- H. P. Lee (2013)
J. Biol. Chem. 288, 26265-26274
   Abstract »    Full Text »    PDF »
Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
C. Bellance, J. A. Khan, G. Meduri, A. Guiochon-Mantel, M. Lombes, and H. Loosfelt (2013)
Mol. Biol. Cell 24, 1363-1374
   Abstract »    Full Text »    PDF »
Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1.
J. Diaz, E. Aranda, S. Henriquez, M. Quezada, E. Espinoza, M. L. Bravo, B. Oliva, S. Lange, M. Villalon, M. Jones, et al. (2012)
J. Endocrinol. 214, 165-175
   Abstract »    Full Text »    PDF »
Phosphorylation by p38 Mitogen-Activated Protein Kinase Promotes Estrogen Receptor {alpha} Turnover and Functional Activity via the SCFSkp2 Proteasomal Complex.
S. Bhatt, Z. Xiao, Z. Meng, and B. S. Katzenellenbogen (2012)
Mol. Cell. Biol. 32, 1928-1943
   Abstract »    Full Text »    PDF »
Antiprogestins in breast cancer treatment: are we ready?.
C. Lanari, V. Wargon, P. Rojas, and A. A. Molinolo (2012)
Endocr. Relat. Cancer 19, R35-R50
   Abstract »    Full Text »    PDF »
ck2-Dependent Phosphorylation of Progesterone Receptors (PR) on Ser81 Regulates PR-B Isoform-Specific Target Gene Expression in Breast Cancer Cells.
C. R. Hagan, T. M. Regan, G. E. Dressing, and C. A. Lange (2011)
Mol. Cell. Biol. 31, 2439-2452
   Abstract »    Full Text »    PDF »
BRCA1 Counteracts Progesterone Action by Ubiquitination Leading to Progesterone Receptor Degradation and Epigenetic Silencing of Target Promoters.
V. Calvo and M. Beato (2011)
Cancer Res. 71, 3422-3431
   Abstract »    Full Text »    PDF »
Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma.
A. A. Tone, C. Virtanen, P. A. Shaw, and T. J. Brown (2011)
Endocr. Relat. Cancer 18, 221-234
   Abstract »    Full Text »    PDF »
Combined Analysis of Estrogen Receptor {beta}-1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome.
L. P. Stabile, S. Dacic, S. R. Land, D. E. Lenzner, R. Dhir, M. Acquafondata, R. J. Landreneau, J. R. Grandis, and J. M. Siegfried (2011)
Clin. Cancer Res. 17, 154-164
   Abstract »    Full Text »    PDF »
Tip30 Deletion in MMTV-Neu Mice Leads to Enhanced EGFR Signaling and Development of Estrogen Receptor-Positive and Progesterone Receptor-Negative Mammary Tumors.
C. Zhang, M. Mori, S. Gao, A. Li, I. Hoshino, M. D. Aupperlee, S. Z. Haslam, and H. Xiao (2010)
Cancer Res. 70, 10224-10233
   Abstract »    Full Text »    PDF »
Murine 12/15-Lipoxygenase Regulates ATP-binding Cassette Transporter G1 Protein Degradation through p38- and JNK2-dependent Pathways.
M. H. Nagelin, S. Srinivasan, J. L. Nadler, and C. C. Hedrick (2009)
J. Biol. Chem. 284, 31303-31314
   Abstract »    Full Text »    PDF »
Epigenetics of endometriosis.
S.-W. Guo (2009)
Mol. Hum. Reprod. 15, 587-607
   Abstract »    Full Text »    PDF »
Activation of estrogen receptor-{alpha} induces gonadotroph progesterone receptor expression and action differently in young and middle-aged ovariectomized rats.
A. Gordon, R. Aguilar, J. C. Garrido-Gracia, S. Guil-Luna, R. Sanchez-Cespedes, Y. Millan, J. Martin de las Mulas, and J. E. Sanchez-Criado (2009)
Hum. Reprod. 24, 2618-2628
   Abstract »    Full Text »    PDF »
Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.
A. R. Daniel and C. A. Lange (2009)
PNAS 106, 14287-14292
   Abstract »    Full Text »    PDF »
Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.
G. E Dressing, C. R Hagan, T. P Knutson, A. R Daniel, and C. A Lange (2009)
Endocr. Relat. Cancer 16, 351-361
   Abstract »    Full Text »    PDF »
Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer.
T. W. Miller, M. Perez-Torres, A. Narasanna, M. Guix, O. Stal, G. Perez-Tenorio, A. M. Gonzalez-Angulo, B. T. Hennessy, G. B. Mills, J. P. Kennedy, et al. (2009)
Cancer Res. 69, 4192-4201
   Abstract »    Full Text »    PDF »
Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation.
H. Abdel-Hafiz, M. L. Dudevoir, and K. B. Horwitz (2009)
J. Biol. Chem. 284, 9099-9108
   Abstract »    Full Text »    PDF »
Activation of Stat3 by Heregulin/ErbB-2 through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth.
C. J. Proietti, C. Rosemblit, W. Beguelin, M. A. Rivas, M. C. Diaz Flaque, E. H. Charreau, R. Schillaci, and P. V. Elizalde (2009)
Mol. Cell. Biol. 29, 1249-1265
   Abstract »    Full Text »    PDF »
Repression of Estrogen Receptor alpha by CDK11p58 Through Promoting its Ubiquitin-Proteasome Degradation.
Y. Wang, H. Zong, Y. Chi, Y. Hong, Y. Yang, W. Zou, X. Yun, and J. Gu (2009)
J. Biochem. 145, 331-343
   Abstract »    Full Text »    PDF »
Ovarian stimulation with FSH reduces phosphorylation of gonadotrope progesterone receptor and LH secretion in the rat.
A. Gordon, J. C Garrido-Gracia, R. Aguilar, S. Guil-Luna, Y. Millan, J. M. de las Mulas, and J. E Sanchez-Criado (2009)
Reproduction 137, 151-159
   Abstract »    Full Text »    PDF »
Differential effects of hydrocortisone and TNF{alpha} on tight junction proteins in an in vitro model of the human blood-brain barrier.
C. Forster, M. Burek, I. A. Romero, B. Weksler, P.-O. Couraud, and D. Drenckhahn (2008)
J. Physiol. 586, 1937-1949
   Abstract »    Full Text »    PDF »
Temporal variation in estrogen receptor-{alpha} protein turnover in the presence of estrogen.
C. C Valley, N. M Solodin, G. L Powers, S. J Ellison, and E. T Alarid (2008)
J. Mol. Endocrinol. 40, 23-34
   Abstract »    Full Text »    PDF »
Histone Deacetylase Inhibitors Reduce Steroidogenesis through SCF-Mediated Ubiquitination and Degradation of Steroidogenic Factor 1 (NR5A1).
W.-Y. Chen, J.-H. Weng, C.-C. Huang, and B.-c. Chung (2007)
Mol. Cell. Biol. 27, 7284-7290
   Abstract »    Full Text »    PDF »
Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells.
D. Nonclercq, F. Journe, I. Laios, C. Chaboteaux, R.-A. Toillon, G. Leclercq, and G. Laurent (2007)
J. Mol. Endocrinol. 39, 105-118
   Abstract »    Full Text »    PDF »
Differential Regulation of Estrogen Receptor {alpha} Turnover and Transactivation by Mdm2 and Stress-Inducing Agents.
V. Duong, N. Boulle, S. Daujat, J. Chauvet, S. Bonnet, H. Neel, and V. Cavailles (2007)
Cancer Res. 67, 5513-5521
   Abstract »    Full Text »    PDF »
CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.
P.-J. Zhang, J. Zhao, H.-Y. Li, J.-H. Man, K. He, T. Zhou, X. Pan, A.-L. Li, W.-L. Gong, B.-F. Jin, et al. (2007)
EMBO J. 26, 1831-1842
   Abstract »    Full Text »    PDF »
Endocrine signaling in ovarian surface epithelium and cancer.
P. C.K. Leung and J.-H. Choi (2007)
Hum. Reprod. Update 13, 143-162
   Abstract »    Full Text »    PDF »
The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone.
A. Romano, B. Delvoux, D.-C. Fischer, and P. Groothuis (2007)
J. Mol. Endocrinol. 38, 331-350
   Abstract »    Full Text »    PDF »
Progesterone Receptors Upregulate Wnt-1 To Induce Epidermal Growth Factor Receptor Transactivation and c-Src-Dependent Sustained Activation of Erk1/2 Mitogen-Activated Protein Kinase in Breast Cancer Cells.
E. J. Faivre and C. A. Lange (2007)
Mol. Cell. Biol. 27, 466-480
   Abstract »    Full Text »    PDF »
Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist.
A. J. Poole, Y. Li, Y. Kim, S.-C. J. Lin, W.-H. Lee, and E. Y.-H. P. Lee (2006)
Science 314, 1467-1470
   Abstract »    Full Text »    PDF »
PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus.
J.-H. Man, H.-Y. Li, P.-J. Zhang, T. Zhou, K. He, X. Pan, B. Liang, A.-L. Li, J. Zhao, W.-L. Gong, et al. (2006)
Nucleic Acids Res. 34, 5552-5566
   Abstract »    Full Text »    PDF »
Turning Off Estrogen Receptor {beta}-Mediated Transcription Requires Estrogen-Dependent Receptor Proteolysis.
Y. Tateishi, R. Sonoo, Y.-i. Sekiya, N. Sunahara, M. Kawano, M. Wayama, R. Hirota, Y.-i. Kawabe, A. Murayama, S. Kato, et al. (2006)
Mol. Cell. Biol. 26, 7966-7976
   Abstract »    Full Text »    PDF »
Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and L{beta}T2 gonadotropes.
J. L Turgeon and D. W Waring (2006)
J. Endocrinol. 190, 837-846
   Abstract »    Full Text »    PDF »
Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
G. B Silberstein, K. Van Horn, E. Hrabeta-Robinson, and J. Compton (2006)
J. Endocrinol. 190, 225-239
   Abstract »    Full Text »    PDF »
Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function.
R. Shao, B. Weijdegard, K. Ljungstrom, A. Friberg, C. Zhu, X. Wang, Y. Zhu, J. Fernandez-Rodriguez, E. Egecioglu, E. Rung, et al. (2006)
Am J Physiol Endocrinol Metab 291, E59-E72
   Abstract »    Full Text »    PDF »
Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response.
M. G. Rosenfeld, V. V. Lunyak, and C. K. Glass (2006)
Genes & Dev. 20, 1405-1428
   Abstract »    Full Text »    PDF »
Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific.
C. Forster, J. Waschke, M. Burek, J. Leers, and D. Drenckhahn (2006)
J. Physiol. 573, 413-425
   Abstract »    Full Text »    PDF »
Brain Corticosteroid Receptor Dynamics and Trafficking: Implications from Live Cell Imaging.
M. Nishi and M. Kawata (2006)
Neuroscientist 12, 119-133
   Abstract »    PDF »
Dual Roles for the Phosphatase PPM1D in Regulating Progesterone Receptor Function.
D. A. Proia, B. W. Nannenga, L. A. Donehower, and N. L. Weigel (2006)
J. Biol. Chem. 281, 7089-7101
   Abstract »    Full Text »    PDF »
Differential Regulation of Estrogen-Inducible Proteolysis and Transcription by the Estrogen Receptor {alpha} N Terminus.
C. C. Valley, R. Metivier, N. M. Solodin, A. M. Fowler, M. T. Mashek, L. Hill, and E. T. Alarid (2005)
Mol. Cell. Biol. 25, 5417-5428
   Abstract »    Full Text »    PDF »
Human Progesterone Receptor Displays Cell Cycle-Dependent Changes in Transcriptional Activity.
R. Narayanan, D. P. Edwards, and N. L. Weigel (2005)
Mol. Cell. Biol. 25, 2885-2898
   Abstract »    Full Text »    PDF »
Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.
H K Kinyamu, J Chen, and T K Archer (2005)
J. Mol. Endocrinol. 34, 281-297
   Abstract »    Full Text »    PDF »
c-Jun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor {alpha}.
H. Srinivas, D. M. Juroske, S. Kalyankrishna, D. D. Cody, R. E. Price, X.-C. Xu, R. Narayanan, N. L. Weigel, and J. M. Kurie (2005)
Mol. Cell. Biol. 25, 1054-1069
   Abstract »    Full Text »    PDF »
Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin A/Cdk2 as a Progesterone Receptor Coactivator.
R. Narayanan, A. A. Adigun, D. P. Edwards, and N. L. Weigel (2005)
Mol. Cell. Biol. 25, 264-277
   Abstract »    Full Text »    PDF »
A therapeutic model for advanced endometrial cancer: Systemic progestin in combination with local adenoviral-mediated progesterone receptor expression.
D. Dai, L. Albitar, T. Nguyen, L. L. Laidler, M. Singh, and K. K. Leslie (2005)
Mol. Cancer Ther. 4, 169-175
   Abstract »    Full Text »    PDF »
Phosphorylation of Progesterone Receptor Serine 400 Mediates Ligand-Independent Transcriptional Activity in Response to Activation of Cyclin-Dependent Protein Kinase 2.
L. K. Pierson-Mullany and C. A. Lange (2004)
Mol. Cell. Biol. 24, 10542-10557
   Abstract »    Full Text »    PDF »
Coactivator AIB1 links estrogen receptor transcriptional activity and stability.
W. Shao, E. K. Keeton, D. P. McDonnell, and M. Brown (2004)
PNAS 101, 11599-11604
   Abstract »    Full Text »    PDF »
Src Kinase and Mitogen-Activated Protein Kinases in the Progression from Normal to Malignant Endometrium.
M. M. Desouki and B. G. Rowan (2004)
Clin. Cancer Res. 10, 546-555
   Abstract »    Full Text »    PDF »
Selective Estrogen Receptor Modulators 4-Hydroxytamoxifen and Raloxifene Impact the Stability and Function of SRC-1 and SRC-3 Coactivator Proteins.
D. M. Lonard, S. Y. Tsai, and B. W. O'Malley (2004)
Mol. Cell. Biol. 24, 14-24
   Abstract »    Full Text »    PDF »
The Divergent Orphan Nuclear Receptor ODR-7 Regulates Olfactory Neuron Gene Expression via Multiple Mechanisms in Caenorhabditis elegans.
M. E. Colosimo, S. Tran, and P. Sengupta (2003)
Genetics 165, 1779-1791
   Abstract »    Full Text »    PDF »
Cytosolic HSP90 associates with and modulates the Arabidopsis RPM1 disease resistance protein.
D. A. Hubert, P. Tornero, Y. Belkhadir, P. Krishna, A. Takahashi, K. Shirasu, and J. L. Dangl (2003)
EMBO J. 22, 5679-5689
   Abstract »    Full Text »    PDF »
The AF-1 and AF-2 Domains of RAR{gamma}2 and RXR{alpha} Cooperate for Triggering the Transactivation and the Degradation of RAR{gamma}2/RXR{alpha} Heterodimers.
M. Gianni, A. Tarrade, E. A. Nigro, E. Garattini, and C. Rochette-Egly (2003)
J. Biol. Chem. 278, 34458-34466
   Abstract »    Full Text »    PDF »
Extracellular Signal-Regulated Kinase 7, a Regulator of Hormone-Dependent Estrogen Receptor Destruction.
L. M. Henrich, J. A. Smith, D. Kitt, T. M. Errington, B. Nguyen, A. M. Traish, and D. A. Lannigan (2003)
Mol. Cell. Biol. 23, 5979-5988
   Abstract »    Full Text »    PDF »
Estrogen Receptor-Dependent Proteasomal Degradation of the Glucocorticoid Receptor Is Coupled to an Increase in Mdm2 Protein Expression.
H. K. Kinyamu and T. K. Archer (2003)
Mol. Cell. Biol. 23, 5867-5881
   Abstract »    Full Text »    PDF »
Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex.
N. Wiper-Bergeron, D. Wu, L. Pope, C. Schild-Poulter, and R. J. G. Hache (2003)
EMBO J. 22, 2135-2145
   Abstract »    Full Text »    PDF »
Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1.
A. Chauchereau, L. Amazit, M. Quesne, A. Guiochon-Mantel, and E. Milgrom (2003)
J. Biol. Chem. 278, 12335-12343
   Abstract »    Full Text »    PDF »
The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor {alpha} through Activation of Proteasomes.
M. Wormke, M. Stoner, B. Saville, K. Walker, M. Abdelrahim, R. Burghardt, and S. Safe (2003)
Mol. Cell. Biol. 23, 1843-1855
   Abstract »    Full Text »    PDF »
Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells.
L. Labriola, M. Salatino, C. J. Proietti, A. Pecci, O. A. Coso, A. R. Kornblihtt, E. H. Charreau, and P. V. Elizalde (2003)
Mol. Cell. Biol. 23, 1095-1111
   Abstract »    Full Text »    PDF »
Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen.
C. Stirone, S. P. Duckles, and D. N. Krause (2003)
Am J Physiol Endocrinol Metab 284, E184-E192
   Abstract »    Full Text »    PDF »
Involvement of Proteasome in the Dynamic Assembly of the Androgen Receptor Transcription Complex.
Z. Kang, A. Pirskanen, O. A. Janne, and J. J. Palvimo (2002)
J. Biol. Chem. 277, 48366-48371
   Abstract »    Full Text »    PDF »
Mechanism of Action of Progesterone Antagonists.
S. A. Leonhardt and D. P. Edwards (2002)
Experimental Biology and Medicine 227, 969-980
   Abstract »    Full Text »    PDF »
The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression.
H. Abdel-Hafiz, G. S. Takimoto, L. Tung, and K. B. Horwitz (2002)
J. Biol. Chem. 277, 33950-33956
   Abstract »    Full Text »    PDF »
Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor.
A. P. Lieberman, G. Harmison, A. D. Strand, J. M. Olson, and K. H. Fischbeck (2002)
Hum. Mol. Genet. 11, 1967-1976
   Abstract »    Full Text »    PDF »
New Human Breast Cancer Cells to Study Progesterone Receptor Isoform Ratio Effects and Ligand-independent Gene Regulation.
B. M. Jacobsen, J. K. Richer, S. A. Schittone, and K. B. Horwitz (2002)
J. Biol. Chem. 277, 27793-27800
   Abstract »    Full Text »    PDF »
In Vivo and in Vitro Phosphorylation of Membrane and Soluble Forms of Soybean Nodule Sucrose Synthase.
O. Komina, Y. Zhou, G. Sarath, and R. Chollet (2002)
Plant Physiology 129, 1664-1673
   Abstract »    Full Text »    PDF »
Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR{gamma} degradation and transactivation.
M. Gianni, A. Bauer, E. Garattini, P. Chambon, and C. Rochette-Egly (2002)
EMBO J. 21, 3760-3769
   Abstract »    Full Text »    PDF »
EDD, the Human Hyperplastic Discs Protein, Has a Role in Progesterone Receptor Coactivation and Potential Involvement in DNA Damage Response.
M. J. Henderson, A. J. Russell, S. Hird, M. Munoz, J. L. Clancy, G. M. Lehrbach, S. T. Calanni, D. A. Jans, R. L. Sutherland, and C. K. W. Watts (2002)
J. Biol. Chem. 277, 26468-26478
   Abstract »    Full Text »    PDF »
The p38 and JNK Pathways Cooperate to trans-Activate Vitamin D Receptor via c-Jun/AP-1 and Sensitize Human Breast Cancer Cells to Vitamin D3-induced Growth Inhibition.
X. Qi, R. Pramanik, J. Wang, R. M. Schultz, R. K. Maitra, J. Han, H. F. DeLuca, and G. Chen (2002)
J. Biol. Chem. 277, 25884-25892
   Abstract »    Full Text »    PDF »
Proteasomal Inhibition Enhances Glucocorticoid Receptor Transactivation and Alters Its Subnuclear Trafficking.
B. J. Deroo, C. Rentsch, S. Sampath, J. Young, D. B. DeFranco, and T. K. Archer (2002)
Mol. Cell. Biol. 22, 4113-4123
   Abstract »    Full Text »    PDF »
Proteasome Inhibitors Reduce Luciferase and {beta}-Galactosidase Activity in Tissue Culture Cells.
B. J. Deroo and T. K. Archer (2002)
J. Biol. Chem. 277, 20120-20123
   Abstract »    Full Text »    PDF »
Phosphorylation by Mitogen-activated Protein Kinase Mediates the Hypoxia-induced Turnover of the TAL1/SCL Transcription Factor in Endothelial Cells.
T. Tang, J. L. Arbiser, and S. J. Brandt (2002)
J. Biol. Chem. 277, 18365-18372
   Abstract »    Full Text »    PDF »
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells.
J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz (2002)
J. Biol. Chem. 277, 5209-5218
   Abstract »    Full Text »    PDF »
Interferon-gamma -mediated Activation and Ubiquitin-Proteasome-dependent Degradation of PPARgamma in Adipocytes.
Z. E. Floyd and J. M. Stephens (2002)
J. Biol. Chem. 277, 4062-4068
   Abstract »    Full Text »    PDF »
HER-2 Amplification Impedes the Antiproliferative Effects of Hormone Therapy in Estrogen Receptor-positive Primary Breast Cancer.
M. Dowsett, C. Harper-Wynne, I. Boeddinghaus, J. Salter, M. Hills, M. Dixon, S. Ebbs, G. Gui, N. Sacks, and I. Smith (2001)
Cancer Res. 61, 8452-8458
   Abstract »    Full Text »    PDF »
Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids.
A. D. Wallace and J. A. Cidlowski (2001)
J. Biol. Chem. 276, 42714-42721
   Abstract »    Full Text »    PDF »
Transcriptional Hyperactivity of Human Progesterone Receptors Is Coupled to Their Ligand-Dependent Down-Regulation by Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Serine 294.
T. Shen, K. B. Horwitz, and C. A. Lange (2001)
Mol. Cell. Biol. 21, 6122-6131
   Abstract »    Full Text »    PDF »
Ligand-Dependent Degradation of Retinoid X Receptors Does Not Require Transcriptional Activity or Coactivator Interactions.
D. L. Osburn, G. Shao, H. M. Seidel, and I. G. Schulman (2001)
Mol. Cell. Biol. 21, 4909-4918
   Abstract »    Full Text »    PDF »
Hepatocyte Nuclear Factor-4{alpha} Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase.
I. Leclerc, C. Lenzner, L. Gourdon, S. Vaulont, A. Kahn, and B. Viollet (2001)
Diabetes 50, 1515-1521
   Abstract »    Full Text »    PDF »
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).
H. Poukka, U. Karvonen, O. A. Janne, and J. J. Palvimo (2000)
PNAS 97, 14145-14150
   Abstract »    Full Text »    PDF »
Dimerization with Retinoid X Receptors and Phosphorylation Modulate the Retinoic Acid-induced Degradation of Retinoic Acid Receptors {alpha} and {gamma} through the Ubiquitin-Proteasome Pathway.
E. Kopf, J.-L. Plassat, V. Vivat, H. de The, P. Chambon, and C. Rochette-Egly (2000)
J. Biol. Chem. 275, 33280-33288
   Abstract »    Full Text »    PDF »
MAP Kinases and the Regulation of Nuclear Receptors.
J. M. Kyriakis (2000)
Sci. STKE 2000, pe1
   Abstract »    Full Text »    PDF »
Dimerization with RXRs and phosphorylation modulate the retinoic acid-induced degradation of RAR{alpha} and RAR{gamma} and through the ubiquitin-proteasome pathway.
E. Kopf, J.-L. Plassat, V. Vivat, H. de The, P. Chambon, and C. Rochette-Egly (2000)
J. Biol. Chem.
   Abstract »
The Classical Progesterone Receptor Associates with p42 MAPK and Is Involved in Phosphatidylinositol 3-Kinase Signaling in Xenopus Oocytes.
C. P. Bagowski, J. W. Myers, and J. E. Ferrell Jr. (2001)
J. Biol. Chem. 276, 37708-37714
   Abstract »    Full Text »    PDF »
The Development-associated Cleavage of Lens Connexin 45.6 by Caspase-3-like Protease Is Regulated by Casein Kinase II-mediated Phosphorylation.
X. Yin, S. Gu, and J. X. Jiang (2001)
J. Biol. Chem. 276, 34567-34572
   Abstract »    Full Text »    PDF »
Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha.
M. T. Preisler-Mashek, N. Solodin, B. L. Stark, M. K. Tyriver, and E. T. Alarid (2002)
Am J Physiol Endocrinol Metab 282, E891-E898
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882